July 1st 2025
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with metastatic colorectal cancer.
OS Disparity, Driver Gene Variations by Race and Ethnicity Seen in CRC
Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike